Fatima A. Jamali
Amman, AM 11942, Jordan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Functional improvements correlate with enhanced quality of life following mesenchymal stromal cell therapy in chronic spinal cord injury.
Journal: Scientific reports
Published: May 05, 2025
Parkinson's Disease Database in the Middle East, North Africa, and South Asia Countries.
Journal: International journal of public health
Published: October 05, 2024
Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Multiple Sclerosis Patients: Phase I/II Dose-Finding Clinical Study.
Journal: Cell transplantation
Published: March 07, 2024
Safety and potential efficacy of expanded mesenchymal stromal cells of bone marrow and umbilical cord origins in patients with chronic spinal cord injuries: a phase I/II study.
Journal: Cytotherapy
Published: September 03, 2023
Safe Reversal of Motor and Sensory Deficits by Repeated High Doses of Mesenchymal Stem Cells in a Patient with Chronic Complete Spinal Cord Injury.
Journal: The American journal of case reports
Published: May 13, 2023
A comparative study of the capability of MSCs isolated from different human tissue sources to differentiate into neuronal stem cells and dopaminergic-like cells.
Journal: PeerJ
Published: October 27, 2021
Validation of the Arabic Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: September 04, 2021
A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study.
Journal: JMIR research protocols
Published: April 16, 2021
The effect of stem cell therapy and comprehensive physical therapy in motor and non-motor symptoms in patients with multiple sclerosis: A comparative study.
Journal: Medicine
Published: August 28, 2020
Anti-oncogenic activities exhibited by paracrine factors of MSCs can be mediated by modulation of KITLG and DKK1 genes in glioma SCs in vitro.
Journal: Molecular therapy oncolytics
Published: August 04, 2020
An insight into the whole transcriptome profile of four tissue-specific human mesenchymal stem cells.
Journal: Regenerative medicine
Published: February 01, 2019
Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy.
Journal: CNS neuroscience & therapeutics
Published: June 03, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026